𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Germ cell tumours of the central nervous system in children—controversies in radiotherapy

✍ Scribed by Borg, Martin


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
96 KB
Volume
40
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Primary germ cell tumours (GCT) of the central nervous system (CNS) are rare tumours of children and adults. As few prospective, randomised trials have been published, management decisions are often based on retrospective and historical studies, histology, age, performance status, and extent of disease at diagnosis. This article reviews the current controversies in the radiotherapeutic management of primary GCT of the CNS.

Procedure

A computerised literature search was performed using the Medline database from 1975 to 2000, this being limited to publications written in the English language on CNS GCT in children up to the age of 16 years.

Results

Issues in radiation therapy currently undergoing review include the role of cranio‐spinal irradiation (CSI), radiation therapy field sizes, the radiation therapy dose, the extent of surgery in combination with radiotherapy, and the role and timing of chemotherapy in combination with radiotherapy.

Conclusions

The excellent outcome in children with pure germinoma of the CNS and the long‐term morbidity associated with standard therapy justifies attempts to limit both the total radiation dose and field sizes, with or without the addition of chemotherapy. The poorer outcome associated with non‐germinoma GCT justifies a more aggressive approach in children, combining chemotherapy, surgery and virgule, or radiation therapy, based on known prognostic factors. Med Pediatr Oncol 2003;40:367–374. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Central nervous system tumours in childr
✍ Patricia A. McKinney 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

In children, a variety of distinct tumour types arise in the central nervous system (CNS) but they are frequently considered by epidemiologists as a single entity. CNS tumours are the second most common childhood malignancy and occur more frequently in developed countries than developing nations. Ap

Primary central nervous system germ cell
✍ C. Ronald Kersh; William C. Constable; Donald R. Eisert; Cynthia A. Spaulding; S 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Primary malignant intracranial germ cell tumors are rare lesions responsible for only 0.5% of all central nervous system (CNS) malignancy. With stereotactic localization these lesions can be safely biopsied, and histologic confirmation will affect the ultimate prognosis. This report is a multi-insti

Radiotherapy of central nervous system t
✍ Skowro?ska-Gardas, Anna 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Background. The prognosis for young children suffering from brain tumors is, as many authors report, generally poor. The probability of late complications in young children is also high, and their quality of life is significantly worse than that of older children. This study presents the experience

Cell-mediated immunity and blocking fact
✍ S. Kumar; G. Taylor; J. K. Steward; M. A. Waghe; P. Morris-Jones 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 893 KB

## Abstract Lymphocytotoxicity studies were carried out in both the autochthonous and allogeneic situations in nine astrocytomas, seven medulloblastomas and two ependy‐momas. Tumour type‐specific lymphocytotoxicity was demonstrated. The degree of lymphocyte‐mediated tumour‐cell killing did not decr

Cell proliferation in the lamprey centra
✍ Ivonne Vidal Pizarro; Gary P. Swain; Michael E. Selzer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract After spinal cord transection, axons regenerate both in larval and adult lampreys. It is not known to what degree cells proliferate, even in the uninjured animal. Therefore, we have determined the prevalence of mitosis in the lamprey central nervous system (CNS). Bromodeoxyuridine (BrdU